Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
Healthy Volunteers
ID07274176

The Effect of Graded Forced Expiration on Intraocular Pressure Using the Airofit Device

Led by Uşak University · Updated on 2025-12-22

60

Participants Needed

1

Research Sites

2 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to understand how intraocular pressure (IOP), an important factor linked to glaucoma risk, changes during controlled respiratory stress using the Airofit device. The study focuses on measuring IOP variations across six different levels of forced expiration to provide detailed information about the relationship between respiratory effort and IOP. This will help establish a new standardized method for studying IOP changes during breathing exercises. Participants will use the Airofit respiratory muscle trainer to perform forced expiration maneuvers at six increasing resistance levels, from Level 1 (lowest) to Level 6 (highest). Each level involves a 5-minute exercise phase of forced expiration, immediately followed by an IOP measurement within 5 seconds. This protocol will be done sequentially for all six levels during a single visit. During the study visit, participants will have baseline IOP measured before starting the exercises. After each 5-minute forced expiration session at each resistance level, IOP will be measured promptly. Researchers will collect a total of seven IOP readings per participant, including the baseline and after each level. The study will include about 60 adults who can follow instructions and have certain eye measurements within set ranges. This single-visit study will provide detailed data on how IOP responds to graded respiratory effort.

CONDITIONS

Brief Title

The Effect of Graded Forced Expiration on Intraocular Pressure

Who Can Participate

Age: 18Years - 65Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 18 years or older
  • Willing and able to provide informed consent
  • Have a best-corrected visual acuity of 6/12 or better
  • Able to understand and follow instructions for using the Airofit device
  • Have an optic nerve cup/disc ratio not exceeding 0.5, and have a cup-to-disc difference between both eyes not exceeding 0.2
  • Have not taken any anticholinergic medication, systemic beta-blockers, or corticosteroids within the last 3 months that could affect intraocular pressure levels
Not Eligible

You will not qualify if you...

  • History of intraocular surgery
  • History of uveitis
  • Spherical refractive error exceeding 3 diopters
  • History of regular topical treatment other than artificial tears

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surveillance

Duration - Single visit

Participants undergo a single session where intraocular pressure measurements are taken before and after performing graded forced expiration exercises using the Airofit device.

1 visit (in-person)

Trial Site Locations

Total: 1 location

1

University of Usak

Uşak, Turkey (Türkiye), 64200

Actively Recruiting

Loading map...

Research Team

A

Ata Baytaroglu, Asst. Prof.

S

Serife N Ciftci, Asst. Prof.

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SCREENING

Number of Arms

1

Similar Trials

Effect of Position and Anesthetic Choice on Intraocular Pres...

Intraocular Pressure

Actively Recruiting

1 location

Effect of Raised End-Tidal pCO2 on Choroidal Volume in Child...

Intraocular Pressure

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here